Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1514823
This article is part of the Research Topic HIV/AIDS: Pathogenesis and Vaccine View all 6 articles

Development and Validation of a Nomogram for Predicting the Outcome of Metabolic Syndrome Among People Living with HIV after Antiretroviral Therapy in China

Provisionally accepted
Yong Jin Yong Jin *Jiaona Zhu Jiaona Zhu *Qingmei Chen Qingmei Chen *Mian Wang Mian Wang *Zhihong Shen Zhihong Shen *Yongquan Dong Yongquan Dong *Xiaoqing Li Xiaoqing Li *
  • Yinzhou No.2 Hospital, Ningbo, China

The final, formatted version of the article will be published soon.

    The prevalence of metabolic syndrome among people living with HIV (PLWH) is increasing worldwide. This study aimed to develop and validate a nomogram to predict the risk of metabolic syndrome in PLWH receiving antiretroviral therapy (ART) in China, accounting for both traditional and HIV-specific risk factors.Methods: A retrospective cohort study was conducted among PLWH receiving ART at a designated treatment center in Yinzhou District, China. A total of 774 patients were randomly assigned to development and validation cohorts in a 5:5 ratio. Predictive variables were identified using the least absolute shrinkage and selection operator and multivariable Cox regression analysis. The model's discriminative ability was assessed using the C-index and the area under the receiver operating characteristic curve (AUC).Calibration was evaluated through calibration plots, and clinical utility was assessed using decision curve analysis (DCA).Results: The nomogram incorporated age, ART regimen, body mass index, fasting blood glucose, high-density lipoprotein cholesterol, and HIV viral load as predictive factors. The C-index was 0.726 in the development cohort and 0.781 in the validation cohort, indicating strong discriminative ability. AUC values for predicting metabolic syndrome at 1, 2, and 3 years were 0.732, 0.728, and 0.737 in the development cohort, and 0.797, 0.803, and 0.783 in the validation cohort. Calibration plots showed strong concordance between predicted and observed outcomes, while DCA affirmed the model's clinical applicability. Conclusion: A user-friendly nomogram incorporating six routinely collected variables was developed and internally validated, which can effectively predict metabolic syndrome in PLWH following ART.

    Keywords: metabolic syndrome, nomogram, Prediction model, HIV, aids

    Received: 21 Oct 2024; Accepted: 04 Feb 2025.

    Copyright: © 2025 Jin, Zhu, Chen, Wang, Shen, Dong and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yong Jin, Yinzhou No.2 Hospital, Ningbo, China
    Jiaona Zhu, Yinzhou No.2 Hospital, Ningbo, China
    Qingmei Chen, Yinzhou No.2 Hospital, Ningbo, China
    Mian Wang, Yinzhou No.2 Hospital, Ningbo, China
    Zhihong Shen, Yinzhou No.2 Hospital, Ningbo, China
    Yongquan Dong, Yinzhou No.2 Hospital, Ningbo, China
    Xiaoqing Li, Yinzhou No.2 Hospital, Ningbo, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.